2016 Q2 Form 10-Q Financial Statement

#000117494716002574 Filed on May 02, 2016

View on sec.gov

Income Statement

Concept 2016 Q2 2015 Q4 2015 Q1
Revenue $173.1M $152.4M $137.0M
YoY Change 22.88% 24.3% -19.38%
Cost Of Revenue $114.0M $104.2M $95.56M
YoY Change 23.42% 17.61% -12.14%
Gross Profit $59.11M $48.20M $41.40M
YoY Change 21.86% 41.93% -32.27%
Gross Profit Margin 34.15% 31.63% 30.23%
Selling, General & Admin $22.91M $22.30M $17.60M
YoY Change 5.03% 16.15% -23.97%
% of Gross Profit 38.76% 46.27% 42.52%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $8.344M $9.500M $8.957M
YoY Change -5.18% -4.04% 0.19%
% of Gross Profit 14.12% 19.71% 21.64%
Operating Expenses $22.91M $22.10M $17.60M
YoY Change 5.03% -62.29% -23.97%
Operating Profit $36.20M $26.10M $23.79M
YoY Change 35.62% -205.93% -37.33%
Interest Expense -$35.00K $0.00 -$40.00K
YoY Change -5.41% 11.11%
% of Operating Profit -0.1% 0.0% -0.17%
Other Income/Expense, Net $171.0K $400.0K $469.0K
YoY Change -70.52% -500.0% 42.55%
Pretax Income $36.37M $26.40M $24.20M
YoY Change 33.36% -206.45% -36.81%
Income Tax $13.09M $9.300M $8.720M
% Of Pretax Income 36.0% 35.23% 36.03%
Net Earnings $23.28M $17.10M $15.50M
YoY Change 32.56% -215.87% -36.25%
Net Earnings / Revenue 13.45% 11.22% 11.32%
Basic Earnings Per Share $1.23 $0.83
Diluted Earnings Per Share $1.21 $881.4K $0.81
COMMON SHARES
Basic Shares Outstanding 18.94M shares 18.68M shares
Diluted Shares Outstanding 19.17M shares 19.24M shares

Balance Sheet

Concept 2016 Q2 2015 Q4 2015 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $80.50M $69.20M $30.80M
YoY Change 31.75% 677.53% -38.15%
Cash & Equivalents $80.46M $69.23M $30.80M
Short-Term Investments
Other Short-Term Assets $13.50M $11.20M $10.50M
YoY Change 15.38% -24.32% -13.93%
Inventory $32.27M $37.10M $29.29M
Prepaid Expenses
Receivables $74.75M $71.72M $63.03M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $201.0M $189.3M $133.6M
YoY Change 24.75% 60.16% -17.01%
LONG-TERM ASSETS
Property, Plant & Equipment $102.0M $103.8M $106.1M
YoY Change -6.79% -6.18% 4.22%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $22.45M $22.79M $27.89M
YoY Change 6.21% -10.79% 5.16%
Total Long-Term Assets $124.5M $126.6M $134.0M
YoY Change -4.68% -7.05% 4.41%
TOTAL ASSETS
Total Short-Term Assets $201.0M $189.3M $133.6M
Total Long-Term Assets $124.5M $126.6M $134.0M
Total Assets $325.4M $315.9M $267.6M
YoY Change 11.57% 24.18% -7.51%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $48.30M $13.07M $33.10M
YoY Change 15.27% 10.83% -27.09%
Accrued Expenses $23.60M $15.97M $26.30M
YoY Change -23.13% 6.71% -1.13%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $77.00M $81.99M $63.01M
YoY Change 2.94% 35.79% -27.1%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $100.0K $100.0K $100.0K
YoY Change 0.0% -50.0% -66.67%
Total Long-Term Liabilities $100.0K $100.0K $100.0K
YoY Change 0.0% -50.0% -66.67%
TOTAL LIABILITIES
Total Short-Term Liabilities $77.00M $81.99M $63.01M
Total Long-Term Liabilities $100.0K $100.0K $100.0K
Total Liabilities $85.70M $88.10M $72.20M
YoY Change 2.39% 27.87% -25.18%
SHAREHOLDERS EQUITY
Retained Earnings $255.7M $239.1M $210.5M
YoY Change 15.26% 20.66% 2.37%
Common Stock $24.77M $29.59M $25.96M
YoY Change -8.7% 16.17% 24.66%
Preferred Stock
YoY Change
Treasury Stock (at cost) $64.73M $64.73M $64.73M
YoY Change 0.0% 4.59% 70.86%
Treasury Stock Shares 5.062M shares 5.062M shares 5.062M shares
Shareholders Equity $239.7M $227.7M $195.4M
YoY Change
Total Liabilities & Shareholders Equity $325.4M $315.9M $267.6M
YoY Change 11.57% 24.18% -7.51%

Cashflow Statement

Concept 2016 Q2 2015 Q4 2015 Q1
OPERATING ACTIVITIES
Net Income $23.28M $17.10M $15.50M
YoY Change 32.56% -215.87% -36.25%
Depreciation, Depletion And Amortization $8.344M $9.500M $8.957M
YoY Change -5.18% -4.04% 0.19%
Cash From Operating Activities $29.40M $17.70M $32.78M
YoY Change -38.88% -28.05% 108.68%
INVESTING ACTIVITIES
Capital Expenditures $6.346M -$4.200M $4.302M
YoY Change -152.88% -75.15% -55.09%
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00 $100.0K
YoY Change -100.0% -100.0%
Cash From Investing Activities -$6.300M -$4.200M -$4.242M
YoY Change -46.61% -75.29% -55.72%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $0.00 $2.841M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -11.80M -4.500M -$6.642M
YoY Change 96.67% -83.21% -41.86%
NET CHANGE
Cash From Operating Activities 29.40M 17.70M $32.78M
Cash From Investing Activities -6.300M -4.200M -$4.242M
Cash From Financing Activities -11.80M -4.500M -$6.642M
Net Change In Cash 11.30M 9.000M $21.90M
YoY Change -62.71% -146.87% -513.66%
FREE CASH FLOW
Cash From Operating Activities $29.40M $17.70M $32.78M
Capital Expenditures $6.346M -$4.200M $4.302M
Free Cash Flow $23.05M $21.90M $28.48M
YoY Change -61.64% -47.23% 364.54%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2016Q2 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
2027000 USD
CY2016Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
80463000 USD
CY2016Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
304745000 USD
CY2015Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
308597000 USD
CY2016Q2 us-gaap Inventory Net
InventoryNet
32274000 USD
CY2016Q2 us-gaap Deferred Tax Assets Liabilities Net Current
DeferredTaxAssetsLiabilitiesNetCurrent
9852000 USD
CY2016Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3631000 USD
CY2016Q2 us-gaap Assets Current
AssetsCurrent
200966000 USD
CY2016Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
202738000 USD
CY2016Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
102007000 USD
CY2016Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
22450000 USD
CY2016Q2 us-gaap Assets
Assets
325423000 USD
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
69225000 USD
CY2016Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
48331000 USD
CY2016Q2 rgr Product Liability Current
ProductLiabilityCurrent
1235000 USD
CY2016Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
18555000 USD
CY2016Q2 us-gaap Workers Compensation Liability Current
WorkersCompensationLiabilityCurrent
5068000 USD
CY2016Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
74746000 USD
CY2016Q2 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
3849000 USD
CY2016Q2 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
8548000 USD
CY2015Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
71721000 USD
CY2016Q2 us-gaap Inventory Gross
InventoryGross
77015000 USD
CY2016Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
24765000 USD
CY2016Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
255685000 USD
CY2016Q2 us-gaap Treasury Stock Shares
TreasuryStockShares
5062347 shares
CY2016Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2016Q2 us-gaap Treasury Stock Value
TreasuryStockValue
64727000 USD
CY2015Q4 us-gaap Inventory Gross
InventoryGross
81278000 USD
CY2015Q4 us-gaap Treasury Stock Value
TreasuryStockValue
64727000 USD
CY2016Q2 us-gaap Stockholders Equity
StockholdersEquity
239748000 USD
CY2016Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
325423000 USD
CY2016Q2 us-gaap Inventory Lifo Reserve
InventoryLIFOReserve
42714000 USD
CY2016Q2 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
173109000 USD
CY2016Q2 us-gaap Cost Of Goods Sold
CostOfGoodsSold
113996000 USD
CY2016Q2 us-gaap Gross Profit
GrossProfit
59113000 USD
CY2016Q2 us-gaap Share Based Compensation
ShareBasedCompensation
632000 USD
CY2016Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
632000 USD
CY2016Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
USD
CY2016Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
8344000 USD
CY2016Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
36372000 USD
CY2016Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
13094000 USD
CY2016Q2 us-gaap Net Income Loss
NetIncomeLoss
23278000 USD
CY2016Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.23
CY2016Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.21
CY2016Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.35
CY2016Q2 us-gaap Dividends Common Stock
DividendsCommonStock
6636000 USD
CY2016Q2 us-gaap Dividends Paidinkind
DividendsPaidinkind
55000 USD
CY2016Q2 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
-14001000 USD
CY2016Q2 us-gaap Adjustments To Additional Paid In Capital Tax Effect From Share Based Compensation
AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation
8792000 USD
CY2015Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
8957000 USD
CY2016Q2 us-gaap Inventory Write Down
InventoryWriteDown
-91000 USD
CY2015Q1 us-gaap Inventory Write Down
InventoryWriteDown
-748000 USD
CY2016Q2 us-gaap Selling Expense
SellingExpense
15074000 USD
CY2016Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7838000 USD
CY2016Q2 us-gaap Operating Expenses
OperatingExpenses
22912000 USD
CY2016Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
36201000 USD
CY2016Q2 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-35000 USD
CY2016Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
206000 USD
CY2016Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
171000 USD
CY2015Q1 us-gaap Share Based Compensation
ShareBasedCompensation
1151000 USD
CY2016Q2 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-4000 USD
CY2015Q1 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
60000 USD
CY2016Q2 us-gaap Deferred Other Tax Expense Benefit
DeferredOtherTaxExpenseBenefit
865000 USD
CY2015Q1 us-gaap Deferred Other Tax Expense Benefit
DeferredOtherTaxExpenseBenefit
3000 USD
CY2016Q2 us-gaap Equity Method Investment Other Than Temporary Impairment
EquityMethodInvestmentOtherThanTemporaryImpairment
USD
CY2015Q1 us-gaap Equity Method Investment Other Than Temporary Impairment
EquityMethodInvestmentOtherThanTemporaryImpairment
12000 USD
CY2016Q2 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
3025000 USD
CY2015Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
13296000 USD
CY2016Q2 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-4916000 USD
CY2015Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-16145000 USD
CY2016Q2 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
5308000 USD
CY2015Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-2690000 USD
CY2016Q2 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-9798000 USD
CY2015Q1 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
2476000 USD
CY2016Q2 rgr Increase Decrease In Product Liability
IncreaseDecreaseInProductLiability
580000 USD
CY2015Q1 rgr Increase Decrease In Product Liability
IncreaseDecreaseInProductLiability
-350000 USD
CY2016Q2 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
471000 USD
CY2015Q1 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
-2599000 USD
CY2016Q2 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-1113000 USD
CY2015Q1 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
3081000 USD
CY2016Q2 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
29429000 USD
CY2015Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
32783000 USD
CY2016Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
6346000 USD
CY2015Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
4302000 USD
CY2016Q2 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
USD
CY2015Q1 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
60000 USD
CY2016Q2 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-6346000 USD
CY2015Q1 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-4242000 USD
CY2016Q2 us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
8792000 USD
CY2015Q1 us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
280000 USD
CY2016Q2 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
14001000 USD
CY2015Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
1000000 USD
CY2016Q2 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
USD
CY2015Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
97000 USD
CY2016Q2 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
USD
CY2015Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
2841000 USD
CY2016Q2 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
6636000 USD
CY2015Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
3178000 USD
CY2016Q2 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-11845000 USD
CY2015Q1 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-6642000 USD
CY2016Q2 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
11238000 USD
CY2015Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
21899000 USD
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
8901000 USD
CY2015Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
30800000 USD
CY2016Q2 us-gaap Basis Of Accounting
BasisOfAccounting
<div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';"> <p style="margin: 0pt; font-family: 'times new roman';"><font style="font-family: 'times new roman', times; font-size: 10pt;">NOTE 1 - BASIS OF PRESENTATION</font></p> <p style="margin: 0pt; text-align: justify; font-family: 'times new roman';"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></p> <p style="margin: 0pt; text-align: justify; text-indent: 27pt; font-family: 'times new roman';"><font style="font-family: 'times new roman', times; font-size: 10pt;">The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States for interim financial information and the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and disclosures required by accounting principles generally accepted in the United States of America for complete financial statements.</font></p> <p style="margin: 0pt; font-family: 'times new roman';"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></p> <p style="margin: 0pt; text-align: justify; text-indent: 27pt; font-family: 'times new roman';"><font style="font-family: 'times new roman', times; font-size: 10pt;">In the opinion of management, the accompanying unaudited condensed consolidated financial statements include all adjustments, consisting of normal recurring accruals, considered necessary for a fair presentation of the results of the interim periods. Operating results for the three months ended April 2, 2016 may not be indicative of the results to be expected for the full year ending December 31, 2016. These financial statements have been prepared on a basis that is substantially consistent with the accounting principles applied in our Annual Report on Form 10-K for the year ended December 31, 2015.</font></p> </div>
CY2016Q2 us-gaap Use Of Estimates
UseOfEstimates
<div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';"> <p style="margin: 0pt; font-family: 'times new roman';"><font style="font-family: 'times new roman', times; font-size: 10pt; text-decoration: underline;">Use of Estimates:</font></p> <p style="margin: 0pt; text-align: justify; font-family: 'times new roman';"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></p> <p style="margin: 0pt; text-align: justify; text-indent: 27pt; font-family: 'times new roman';"><font style="font-size: 10pt; font-family: 'times new roman', times;">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates.</font></p> </div>
CY2016Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
12060000 USD
CY2015Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
16637000 USD
CY2016Q2 us-gaap Inventory Work In Process And Raw Materials
InventoryWorkInProcessAndRawMaterials
64955000 USD
CY2015Q4 us-gaap Inventory Work In Process And Raw Materials
InventoryWorkInProcessAndRawMaterials
64641000 USD
CY2016Q2 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
40000000 USD
CY2016Q2 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
shares
CY2016Q2 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2016Q2 us-gaap Defined Contribution Plan Administrative Expenses
DefinedContributionPlanAdministrativeExpenses
1000000 USD
CY2016Q2 rgr Estimated Cost For Defined Benefit Plans
EstimatedCostForDefinedBenefitPlans
3000000 USD
CY2016Q2 rgr Defined Benefit Plan Contributions By Employer For Remainder Of Fiscal Year
DefinedBenefitPlanContributionsByEmployerForRemainderOfFiscalYear
3500000 USD
CY2015Q1 us-gaap Defined Contribution Plan Administrative Expenses
DefinedContributionPlanAdministrativeExpenses
700000 USD
CY2016Q2 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
1700000 USD
CY2015Q1 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
1200000 USD
CY2016Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.360 pure
CY2016Q2 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
4600000 USD
CY2016Q2 rgr Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageGrantDateFairValue
CY2016Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
shares
CY2016Q2 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
8.95
CY2015Q4 rgr Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageGrantDateFairValue
6.69
CY2016Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
shares
CY2016Q2 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
CY2016Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
CY2016Q2 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2 pure
CY2016Q2 us-gaap Loss Contingency Pending Claims Number
LossContingencyPendingClaimsNumber
4 pure
CY2016Q2 rgr Threshold Limit Of Losses Per Transaction For Taking Insurance Coverage On Annual Basis
ThresholdLimitOfLossesPerTransactionForTakingInsuranceCoverageOnAnnualBasis
5000000 USD
CY2016Q2 rgr Threshold Limit Of Aggregate Loss For Insurance Coverage On Annual Basis Excluding New Claims From Governments Or Municipalities
ThresholdLimitOfAggregateLossForInsuranceCoverageOnAnnualBasisExcludingNewClaimsFromGovernmentsOrMunicipalities
10000000 USD
CY2015 us-gaap Loss Contingency Damages Sought Value
LossContingencyDamagesSoughtValue
100000 USD
CY2015Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
100000 USD
CY2016Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
18943427 shares
CY2015Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
18678485 shares
CY2016Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
225150 shares
CY2015Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
561052 shares
CY2016Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
19168577 shares
CY2015Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
19239537 shares
CY2016Q2 rgr Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageGrantDateFairValue
CY2016Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
11838 shares
CY2016Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
8.95
CY2016Q2 rgr Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageGrantDateFairValue
6.69
CY2016Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
700000 USD
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
11838 shares
CY2014 us-gaap Loss Contingency Damages Sought Value
LossContingencyDamagesSoughtValue
0 USD
CY2016Q2 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2016
CY2016Q2 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2016Q2 dei Document Type
DocumentType
10-Q
CY2016Q2 dei Trading Symbol
TradingSymbol
RGR
CY2016Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
18962738 shares
CY2016Q2 dei Amendment Flag
AmendmentFlag
false
CY2016Q2 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2016Q2 dei Document Period End Date
DocumentPeriodEndDate
2016-04-02
CY2015Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.360 pure
CY2016Q2 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2016Q2 dei Entity Registrant Name
EntityRegistrantName
STURM RUGER & CO INC
CY2016Q2 dei Entity Central Index Key
EntityCentralIndexKey
0000095029
CY2016Q2 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';"> <p style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px;"><u>Reclassifications:</u></p> <p style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify;">&#160;</p> <p style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify; text-indent: 0.5in;">Certain prior period balances have been reclassified to conform to current year presentation.&#160;</p> </div>

Files In Submission

Name View Source Status
0001174947-16-002574-index-headers.html Edgar Link pending
0001174947-16-002574-index.html Edgar Link pending
0001174947-16-002574.txt Edgar Link pending
0001174947-16-002574-xbrl.zip Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
ex32-2.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
form10q-15794_rgr.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
rgr-20160402.xml Edgar Link completed
rgr-20160402.xsd Edgar Link pending
rgr-20160402_cal.xml Edgar Link unprocessable
rgr-20160402_def.xml Edgar Link unprocessable
rgr-20160402_lab.xml Edgar Link unprocessable
rgr-20160402_pre.xml Edgar Link unprocessable
Show.js Edgar Link pending